Rodrygo is still adored on MerseysideAccording to Spanish news outlet Fichajes, the Reds are "prepared to to put on the table an offer close to 90 million euros" for 24-year-old Rodrygo Goes. He is ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...
Pharmaceutical companies, telehealth platforms, and digital apps are reshaping how GLP-1 treatments are prescribed, marketed, ...
A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.
She's in bed waiting, and you can't track down where on your body that smell is coming from. Make sure you're clean for her ...
Pharmaceutical Technology on MSN

UK approves Gilead’s twice-yearly HIV PrEP drug

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...
On top of offering various PrEP and PEP medications to students, Student Health expanded its HIV prevention medications this semester with lenacapavir, a twice-per-year injection the Food and Drug ...
Offering diverse PrEP options enhances adherence and reduces HIV cases, with injectable forms showing promise due to less frequent dosing. The study found that MSM in Australia prefer various PrEP ...